Targeted Next Generation Sequencing (tNGS) for detection of drug-resistant tuberculous meningitis: Is this sequencing technology ready for prime time?

This publication has 12 references indexed in Scilit:

• Targeted sequencing from cerebrospinal fluid for rapid identification of drug-resistant tuberculous meningitis
  Journal of Clinical Microbiology, 2024
• Improving Technology to Diagnose Tuberculous Meningitis: Are We There Yet?
  Frontiers in Neurology, 2022
• Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field
  Frontiers in Microbiology, 2022
• A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB® Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical Samples
  Frontiers in Cellular and Infection Microbiology, 2021
• Targeted next generation sequencing directly from sputum for comprehensive genetic information on drug resistant Mycobacterium tuberculosis
  Tuberculosis, 2021
• Evaluation of CSF pyrosequencing to diagnose tuberculous meningitis: A retrospective diagnostic accuracy study
  Tuberculosis, 2021
• Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs
  European Respiratory Journal, 2020
• Utility of pyrosequencing for rapid detection of tubercular meningitis (TBM) and associated susceptibility directly from CSF specimens
  Tuberculosis, 2018
• Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey
  Scientific Reports, 2017
• Evaluation of Pyrosequencing for Detecting Extensively Drug-Resistant Mycobacterium tuberculosis among Clinical Isolates from Four High-Burden Countries
  Antimicrobial Agents and Chemotherapy, 2015